← Back

QuantrolOx 🇫🇮

Series A · €12m

ML-driven Quantum EDGE platform automating tuning and characterisation of superconducting quantum computers. Espoo, Finland.

About QuantrolOx

QuantrolOx offers a measurement and automation platform called Quantum EDGE, designed to enhance the efficiency of superconducting quantum computers by automating tuning and optimization processes, significantly reducing experiment times. The platform employs machine learning to facilitate automated workflows across various quantum technology applications, including material research and quantum processor development.

QuantrolOx is a Finland-based company founded in 2021, now around 34 people. It has raised $14.2M in disclosed funding. FundFinder classes it as DeepTech & Space.

Founded by Vishal Chatrath (Co-Founder & CEO; repeat founder; previously -, Chleon Automotive Ltd.; National University of Singapore), Andrew Briggs (Executive Chair and Co-Founder QuantrolOx Ltd; University of Cambridge), Dominic Lennon (Director of Product & Co-founder; repeat founder; previously Periplus AG, Stealth Company (Dominic Lennon); University of Oxford).

Its investors also appear on FundFinder's most-active lists for Seed · AI (93 funds), Series A · Fintech (84 funds), Seed · DeepTech (80 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on QuantrolOx? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series A · €12m · Oct 2026

  • Hoxton Ventures — Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. · cheques £250k – £5M

Read the announcement ↗

Seed · Sep 2025

Funding history

Sep 2025SeedVoima Ventures
Oct 2026Series A · €12mHoxton Ventures

● rounds tracked in this directory · ○ earlier rounds web-verified from public announcements. Amounts as announced; undisclosed rounds omitted.

Raising your own round? See which European funds fit →